Cardinal Health vs Takeda Pharmaceutical
Cardinal Health (CAH), health care, and Takeda Pharmaceutical (TAK), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Takeda Pharmaceutical is worth $69.3B on the stock market and Cardinal Health $65.4B: Takeda Pharmaceutical is valued at 6% more. Cardinal Health trades at 36.6 times earnings and Takeda Pharmaceutical at 310; operating margins in their latest fiscal years were 1.03% and 0.14%. Over the past year Cardinal Health's share price has moved +37.1% and Takeda Pharmaceutical's +53.4%.
Key facts
- Cardinal Health market value
- $65.4B
- Takeda Pharmaceutical market value
- $69.3B
- Cardinal Health P/E
- 36.6
- Takeda Pharmaceutical P/E
- 310
- Cardinal Health revenue
- $254.2BFY to 2026-06-30
- Takeda Pharmaceutical revenue
- $28.2BFY to 2026-03-31
- Superinvestors holding both
- 1
Market values as of .
| Measure | Cardinal Health | Takeda Pharmaceutical |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2026-06-30 | 2026-03-31 |
| Size | ||
| Market cap | $65.4Blower | $69.3Bhigher |
| Revenue | $254.2Bhigher | $28.2Blower |
| Earnings | $1.7Bhigher | -$954.4Mlower |
| Employees | 58,788higher | 47,029lower |
| Total assets | $57.3Blower | $97.1Bhigher |
| Valuation | ||
| P/E | 36.6lower | 310higher |
| P/S | 0.3lower | 2.5higher |
| P/B | — | — |
| Dividend yield | 0.72% | — |
| Profitability | ||
| Operating margin | 1.03%higher | 0.14%lower |
| Balance sheet | ||
| Net assets | -$2.9Blower | $46.5Bhigher |
| Total liabilities | $60Bhigher | $50.6Blower |
| Total debt | $8.9Blower | $30.6Bhigher |
| Cash on hand | $4.9Bhigher | $3.7Blower |
| Price change | ||
| Today | -0.36%lower | +0.46%higher |
| 1 year | +37.1%lower | +53.4%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (1)
- Charles Brandes (founder)0.4% / 0.5%
Cardinal Health only (5)
Takeda Pharmaceutical only (1)
- Richard Pzena<0.1%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Cardinal Health / Takeda Pharmaceutical). Who owns CAH · Who owns TAK
More on Cardinal Health
Further comparisons
Cardinal Health against its closest peers
Takeda Pharmaceutical against its closest peers
Learn
Questions and answers
Which is bigger, Cardinal Health or Takeda Pharmaceutical?
By market value, Takeda Pharmaceutical is the larger: $69.3B against $65.4B for Cardinal Health. By revenue in its latest fiscal year, Cardinal Health is the larger: $254.2B against $28.2B for Takeda Pharmaceutical.
Which has the higher P/E ratio?
Takeda Pharmaceutical: 310, against 36.6 for Cardinal Health. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Cardinal Health: 1.03%, against 0.14% for Takeda Pharmaceutical. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has more debt?
Takeda Pharmaceutical: $30.6B, against $8.9B for Cardinal Health. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Cardinal Health and Takeda Pharmaceutical?
In their latest 13F filings, Charles Brandes (founder) holds both.
Cite this page
Funkfolio, “Cardinal Health vs Takeda Pharmaceutical”, data as of 17 November 2026. https://funkfolio.com/compare/cah-vs-tak
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.